Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | GPR174 | Q9BXC1 | 1/20 | 0.36 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 4/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | MGAM | O43451 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL237530 | 0.79 | GPR174 (0.34) | MAPTGPR174MEN1KMT2ANPSR1 | |
| SCHEMBL2355439 | 0.77 | MAPT (0.42) | MAPTMGAMESR1ESR2NR1H2 | |
| SCHEMBL16325251 | 0.77 | MAPT (0.38) | MAPTMGAMESR1ESR2NR1H2 | |
| SCHEMBL234084 | 0.77 | GPR174 (0.33) | MAPTGPR174MEN1KMT2ANPSR1 | |
| SCHEMBL236260 | 0.77 | GPR174 (0.33) | MAPTGPR174 | |
| SCHEMBL852348 | 0.76 | GPR174 (0.37) | MAPTGPR174PAX8MEN1KMT2A | |
| SCHEMBL22200091 | 0.75 | MAPT (0.56) | MAPTPAX8MEN1KMT2ANPSR1 | |
| SCHEMBL869282 | 0.75 | MAPT (0.39) | MAPTMGAMESR1ESR2NR1H2 | |
| SCHEMBL238284 | 0.74 | LMNA (0.32) | MAPTGPR174MEN1KMT2ANPSR1 | |
| SCHEMBL237429 | 0.74 | MEN1 (0.33) | MAPTGPR174MEN1KMT2ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10553824-B2 | Encapsulation composition for organic electronic device, and encapsulation formed using same | MOMENTIVE PERFORMANCE MATERIALS KOREA CO., LTD. (KR) | 2020-02-04 | — | — | US | claimed |
| US-20190341579-A1 | ENCAPSULATION COMPOSITION FOR ORGANIC ELECTRONIC DEVICE, AND ENCAPSULATION FORMED USING SAME | MOMENTIVE PERFORMANCE MATERIALS INC. | 2019-11-07 | — | — | US | claimed |
| EP-3565014-A1 | ENCAPSULATION COMPOSITION FOR ORGANIC ELECTRONIC DEVICE, AND ENCAPSULATION FORMED USING SAME | Momentive Performance Materials Korea Co., Ltd. (KR) | 2019-11-06 | — | — | EP | claimed |
| EP-1898264-B1 | Toner compositions | XEROX CORP (US) | 2016-04-06 | — | — | EP | claimed |
| US-8969429-B2 | Low-tack, hydrophobic ophthalmic device materials | NOVARTIS AG (CH) | 2015-03-03 | — | — | US | claimed |
| EP-2673666-B1 | LOW-TACK, HYDROPHOBIC OPHTHALMIC DEVICE MATERIALS | NOVARTIS AG (CH) | 2014-12-31 | — | — | EP | claimed |
| EP-2673666-A1 | LOW-TACK, HYDROPHOBIC OPHTHALMIC DEVICE MATERIALS | Novartis AG (CH) | 2013-12-18 | — | — | EP | claimed |
| WO-2012109228-A1 | LOW-TACK, HYDROPHOBIC OPHTHALMIC DEVICE MATERIALS | NOVARTIS AG (CH) | 2012-08-16 | — | — | WO | claimed |
| US-20120202916-A1 | Low-Tack, Hydrophobic Ophthalmic Device Materials | NOVARTIS AG (CH) | 2012-08-09 | — | — | US | claimed |
| US-8142970-B2 | Toner compositions | XEROX CORPORATION (US) | 2012-03-27 | — | — | US | claimed |
| WO-2004076566-A1 | ORGANIC-INORGANIC HYBRID COMPOSITE, PREPARATION THEREOF AND ANTI-FOGGING COATING COMPOSITION COMPRISING SAME | LUVANTIX CO., LTD. (KR) | 2004-09-10 | — | — | WO | claimed |
| EP-4749682-A1 | CURABLE COMPOSITION, FILM FORMING METHOD, AND METHOD FOR PRODUCING ARTICLE | Canon Kabushiki Kaisha (JP) | 2026-05-27 | — | — | EP | disclosed |
| US-20260140445-A1 | CURABLE COMPOSITION AND METHODS FOR FORMING FILM AND MANUFACTURING ARTICLE | CANON KK (JP) | 2026-05-21 | — | — | US | disclosed |
| US-20260126725-A1 | CURABLE COMPOSITION AND METHODS FOR FORMING FILM AND MANUFACTURING ARTICLE | CANON KK (JP) | 2026-05-07 | — | — | US | disclosed |
| EP-4738008-A1 | CURABLE COMPOSITION AND METHODS FOR FORMING FILM AND MANUFACTURING ARTICLE | Canon Kabushiki Kaisha (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-6506537-B2 | Photopolymerization | JSR CORPORATION (JP) | 2003-01-14 | — | — | US | disclosed |
| EP-1187882-A1 | CHROMIUM-FREE CORROSION PREVENTIVE AND CORROSION PREVENTION METHOD | Henkel Kommanditgesellschaft auf Aktien (DE) | 2002-03-20 | — | — | EP | disclosed |
| US-20020012872-A1 | Radiation-sensitive resin composition | JSR CORPORATION (JP) | 2002-01-31 | — | — | US | disclosed |
| EP-1164433-A1 | Radiation-sensitive resin composition | JSR Corporation (JP) | 2001-12-19 | — | — | EP | disclosed |
| WO-2000069978-A1 | CHROMIUM-FREE CORROSION PREVENTIVE AND CORROSION PREVENTION METHOD | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260126725-A1 | CURABLE COMPOSITION AND METHODS FOR FORMING FILM AND MANUFACTURING ARTICLE | ATM, ATR, PIEZO1 | MAPT 74/4885GPR174 4754/4885PAX8 2135/4885 |
| US-20260140445-A1 | CURABLE COMPOSITION AND METHODS FOR FORMING FILM AND MANUFACTURING ARTICLE | CFL1, ATM, PSPC1 | MAPT 332/4885GPR174 4673/4885PAX8 1406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.